SA
Log In
RGEN
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
23 analysts·High coverage
73
Score
20 Buy (87%)3 Hold (13%)0 Sell (0%)
Rating Breakdown
Strong Buy
14%
Buy
1983%
Hold
313%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$145.00
+15.3%
Consensus
$160.00
+27.2%
Bull
$200.00
+59.0%
12-Month Target Range23 analysts
$145.00$160.00$200.00
Current $125.78Consensus
Current Price
$125.78
Upside to Consensus
$34.22

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+14.65%
EPS+29.65%
FY2028
Rev+15.44%
EPS+28.60%
FY2029
Rev+16.17%
EPS+34.34%

Earnings Surprises

Recent Analyst Actions

Apr 20, 2026Canaccord Genuity
Repligen price target lowered to $145 from $165 at Canaccord
Target:$145.00
+9.7%from $132.19
Apr 17, 2026Redburn Partners
Repligen initiated with a Buy at Rothschild & Co Redburn
Target:$160.00
+25.9%from $127.09
Apr 14, 2026Barclays
Repligen price target lowered to $145 from $175 at Barclays
Target:$145.00
+18.3%from $122.59
Jan 16, 2026UBS
Repligen price target raised to $200 from $190 at UBS
Target:$200.00
+23.7%from $161.69
Dec 15, 2025Wells Fargo
Repligen price target raised to $190 from $175 at Wells Fargo
Target:$190.00
+20.8%from $157.33
Dec 15, 2025Barclays
Repligen price target raised to $200 from $175 at Barclays
Target:$200.00
+27.1%from $157.33
Oct 29, 2025Canaccord Genuity
Repligen price target raised to $165 from $150 at Canaccord
Target:$165.00
+8.9%from $151.57
Oct 29, 2025Barclays
Repligen price target raised to $175 from $160 at Barclays
Target:$175.00
+15.5%from $151.57
Oct 28, 2025Jefferies
Repligen (RGEN) PT Raised to $160 at Jefferies
Target:$160.00
+3.7%from $154.24
Oct 2, 2025Barclays
Repligen price target raised to $160 from $150 at Barclays
Target:$160.00
+9.7%from $145.81
Oct 1, 2025HSBC
Repligen initiated with a Buy at HSBC
Target:$150.00
+12.2%from $133.67
Sep 2, 2025RBC Capital
Repligen price target raised to $205 from $204 at RBC Capital
Target:$205.00
+69.9%from $120.69
Nov 12, 2024KeyBanc
KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Target:$220.00
+48.1%from $148.59
Jul 31, 2024UBS
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Target:$185.00
+10.5%from $167.35
Jul 31, 2024J.P. Morgan
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Target:$200.00
+19.5%from $167.35
Jun 26, 2024Deutsche Bank
Deutsche Bank Upgrades Repligen (RGEN) to Buy
Target:$155.00
+22.0%from $127.00
Jun 21, 2024Stifel Nicolaus
Stifel Out Positive on Repligen (RGEN): 'current levels seem as though they will have proven to be good ones'
Target:$207.00
+68.1%from $123.16
Jan 6, 2023Leerink Partners
SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $200
Target:$200.00
+30.4%from $153.32
Dec 14, 2022Deutsche Bank
Deutsche Bank Initiates Coverage On Repligen with Hold Rating, Announces Price Target of $180
Target:$180.00
+1.1%from $177.99
Dec 7, 2022RBC Capital
RBC Capital Initiates Coverage On Repligen with Sector Perform Rating, Announces Price Target of $190
Target:$190.00
+12.3%from $169.13
Apr 28, 2022Leerink Partners
SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $220
Target:$220.00
+39.7%from $157.51

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance